Start free
← Back to Current Affairs
Current Affairs · 8 November 2026

NPPA Caps Trade Margin on 137 Anti-Cancer Drugs

UPSCPIBSource: PIB
1

Why in News

  • The National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has fixed trade margin limits on the maximum retail price (MRP) of 137 anti-cancer drugs.
  • The decision follows recommendations of an expert committee constituted on 17 October 2026 by the Directorate General of Health Services (DGHS) under the Ministry of Health and Family Welfare.
  • Revised prices will come into effect from 9 November 2026, with an estimated annual saving of about Rs 3,502.31 crore for consumers.
  • So far, 76 drug companies have reported revised MRPs for 1,225 formulations across 121 anti-cancer drugs, with 1,031 formulations showing a reduction in MRP.
2

What is the issue

  • Affordability of cancer treatment: Cancer drugs are often priced high, limiting access for patients; capping trade margins aims to reduce the gap between the cost of production and the MRP.
  • Trade margin rationalisation (TMR): The government is regulating margins at each stage of the supply chain rather than fixing the retail price directly, a departure from traditional price control.
  • Stakeholders: Patients and consumers benefit from lower prices; manufacturers and dealers may see reduced margins; the NPPA and State Drug Controllers are responsible for implementation and monitoring.
  • Legal framework: The notification SO 5690(E) dated 17 October 2026 will remain in force until further orders, while manufacturers can still avail annual price increases under Paragraph 20(1) of the Drugs (Prices Control) Order, 2013, subject to a maximum trade margin of 30%.
  • Coverage gap: Of the 137 drugs identified, 10 to 15 are yet to be launched in the Indian market; margin rationalisation will apply once they are introduced.
  • Transparency and enforcement: Retailers, dealers, hospitals and institutions must prominently display revised MRP lists; consumers can check prices via the Pharma Sahi Dam mobile app and the NPPA website.
Detailed analysis

The full analysis is in the app

This page is the summary. The detailed analysis of this story covers:

What is the statusWhat are the challengesWhat measuresWhat lies aheadImportant Data PointsBackgroundKey Important PointsPrelims RelatedMains RelatedImportant WordsKey conceptsPrevious year questions
Open in Quorum IAS